Inhibitors of carbonic anhydrase IX
US8877970B2 · kind B2 · utility
32Cited by
8References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 8, 2009 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Jul 3, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel radiopharmaceuticals that are useful in diagnostic imaging and therapeutic treatment of disease characterized by over expression of CA-IX comprise a complex that contains a sulfonamide moiety which is capable of binding the active catalytic site of CA-IX, and a radionuclide adapted for radioimaging and/or radiotherapy:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.